LRIA
ABBV icon

Leonard Rickey Investment Advisors’s AbbVie ABBV Stock Holding History

Leonard Rickey Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Sell
1,873
-375
-17% -$80.7K 0.07% 73
2026
Q1 		$489K Buy
2,248
+205
+10% +$45.5K 0.08% 68
2025
Q4 		$467K Sell
2,043
-14
-0.7% -$3.19K 0.08% 75
2025
Q3 		$476K Buy
2,057
+2
+0.1% +$407 0.09% 68
2025
Q2 		$381K Sell
2,055
-231
-10% -$42.9K 0.08% 75
2025
Q1 		$409K Sell
2,286
-203
-8% -$39.5K 0.09% 62
2024
Q4 		$442K Buy
2,489
+17
+0.7% +$3.13K 0.1% 61
2024
Q3 		$488K Sell
2,472
-46
-2% -$8.59K 0.11% 61
2024
Q2 		$432K Buy
2,518
+446
+22% +$73.9K 0.1% 61
2024
Q1 		$377K Buy
2,072
+30
+1% +$5.17K 0.1% 60
2023
Q4 		$316K Buy
2,042
+20
+1% +$2.92K 0.09% 61
2023
Q3 		$301K Buy
2,022
+82
+4% +$12K 0.1% 60
2023
Q2 		$261K Buy
1,940
+208
+12% +$30.5K 0.1% 61
2023
Q1 		$276K Buy
1,732
+9
+0.5% +$1.38K 0.11% 54
2022
Q4 		$279K Buy
+1,723
New +$264K 0.12% 53
2022
Q3 		– Sell
-1,330
Closed -$204K – 60
2022
Q2 		$204K Sell
1,330
-160
-11% -$24.4K 0.09% 62
2022
Q1 		$242K Hold
1,490
– – 0.09% 61
2021
Q4 		$202K Buy
+1,490
New +$176K 0.07% 72
2020
Q3 		– Sell
-3,357
Closed -$330K – 59
2020
Q2 		$330K Sell
3,357
-43
-1% -$3.79K 0.21% 39
2020
Q1 		$259K Buy
3,400
+8
+0.2% +$681 0.2% 47
2019
Q4 		$300K Sell
3,392
-5
-0.1% -$415 0.18% 54
2019
Q3 		$257K Sell
3,397
-82
-2% -$5.62K 0.17% 57
2019
Q2 		$253K Buy
3,479
+215
+7% +$16.9K 0.17% 60
2019
Q1 		$263K Buy
+3,264
New +$267K 0.19% 57

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Leonard Rickey Investment Advisors's ABBV Position: Q2 2026 in Review

Leonard Rickey Investment Advisors reduced its AbbVie (ABBV) stake by 17% in Q2 2026, selling an estimated $80.7K and leaving 1,873 shares worth $471K. The position accounts for 0.07% of the portfolio, ranked #73.

Leonard Rickey Investment Advisors first reported a position in ABBV in Q1 2019 and has held it in 24 quarters since. The position peaked at $489K in Q1 2026. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Leonard Rickey Investment Advisors held 1,873 shares of AbbVie worth $471K as of Q2 2026.
  • Leonard Rickey Investment Advisors sold 375 AbbVie shares in Q2 2026, an estimated $80.7K.
  • AbbVie made up 0.07% of Leonard Rickey Investment Advisors's portfolio in Q2 2026, its #73 holding.
  • Leonard Rickey Investment Advisors first reported a position in AbbVie in Q1 2019 and has held it in 24 quarters since.
  • Leonard Rickey Investment Advisors's AbbVie position peaked at $489K in Q1 2026.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leonard Rickey Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.